In the subgroup with 17p deletion or TP53 mutation, zanubrutinib outperformed others with the most favorable HR (0.52) and the highest SUCRA value of 97%.

From bipolar disorder to hepatitis, and from strokes to development of magnetic resonance imaging, research tied to NIH ...

Every day a child in Romania is diagnosed with cancer. Every day a family in our country enters the battle with a disease ...

The virus is spreading with greater speed among animals, with transmission to humans increasing. But risk to the general ...

Bio-Techne Corporation , a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Transposase mRNA for the TcBustertm non-viral genome ...